Key result
Elimination of fibrin γ-chain cross-linking in FGG3X mice resulted in a 1.5-fold increase in pulmonary emboli count compared to wild-type mice, demonstrating its essential role in clot stability.
Why the study?
Anticoagulation for venous thromboembolism is suboptimal for preventing embolic events, prompting investigation into clot structural and mechanical properties and how they influence in vivo embolism.
Does the elimination of fibrin γ-chain cross-linking by FXIIIa increase pulmonary embolism arising from inferior vena cava thrombi in mice?
Does the elimination of fibrin γ-chain cross-linking by FXIIIa increase pulmonary embolism arising from inferior vena cava thrombi in mice?
Elimination of fibrin γ-chain cross-linking reduces clot stability and increases pulmonary embolism in a murine model, highlighting its critical role in preventing thromboembolism.
Answers are grounded in this paper and cite their sources.
Supports fibrin cross-linking for clot stability in mice; leaves open whether FXIIIa targeting affects human thromboembolism risk.
The onset of venous thromboembolism, including pulmonary embolism, represents a significant health burden affecting more than 1 million people annually worldwide. Current treatment options are based on anticoagulation, which is suboptimal for preventing further embolic events. In order to develop better treatments for thromboembolism, we sought to understand the structural and mechanical properties of blood clots and how this influences embolism in vivo. We developed a murine model in which fibrin γ-chain cross-linking by activated Factor XIII is eliminated (FGG3X) and applied methods to study thromboembolism at whole-body and organ levels. We show that FGG3X mice have a normal phenotype, with overall coagulation parameters and platelet aggregation and function largely unaffected, except for total inhibition of fibrin γ-chain cross-linking. Elimination of fibrin γ-chain cross-linking resulted in thrombi with reduced strength that were prone to fragmentation. Analysis of embolism in vivo using Xtreme optical imaging and light sheet microscopy demonstrated that the elimination of fibrin γ-chain cross-linking resulted in increased embolization without affecting clot size or lysis. Our findings point to a central previously unrecognized role for fibrin γ-chain cross-linking in clot stability. They also indirectly indicate mechanistic targets for the prevention of thrombosis through selective modulation of fibrin α-chain but not γ-chain cross-linking by activated Factor XIII to reduce thrombus size and burden, while maintaining clot stability and preventing embolism.
No takes yet. Share an insight, caveat, or question.
Duval et al. (2021) studied Venous thromboembolism and pulmonary embolism. FGG3X mutation (elimination of fibrin γ-chain cross-linking) vs. Wild-type mice was evaluated on Pulmonary emboli count (1.5-fold increase, p=<0.001). Elimination of fibrin γ-chain cross-linking in FGG3X mice resulted in a 1.5-fold increase in pulmonary emboli count compared to wild-type mice, demonstrating its essential role in clot stability.
Synapse has enriched 10 related papers. Consider them for comparative context: